This example is poorly chosen for a different reason explained in my comment.
Alternatively, we can look at novel curative intent therapies for cancer like focal ablation or stereotactic radiation.
The recurring customer alternative of chemo/immunotherapy or the conventional surgical option are at least an order of magnitude more expensive.
You won’t find much novel systemic therapy that’s curative intent because it’s really hard (?impossible) to do, not because the system wants to make more money slowly killing patients.
This example is poorly chosen for a different reason explained in my comment.
Alternatively, we can look at novel curative intent therapies for cancer like focal ablation or stereotactic radiation.
The recurring customer alternative of chemo/immunotherapy or the conventional surgical option are at least an order of magnitude more expensive.
You won’t find much novel systemic therapy that’s curative intent because it’s really hard (?impossible) to do, not because the system wants to make more money slowly killing patients.